Skip to Content

D5 Logo (Tradjenta 5 mg)

Generic Name: linagliptin

Pill with imprint D5 Logo is Red, Round and has been identified as Tradjenta 5 mg. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc..

Tradjenta is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Tradjenta 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for D5 Logo

Tradjenta 5 mg D5 Logo
Tradjenta 5 mg D5 Logo Front
Tradjenta 5 mg D5 Logo Back
Tradjenta 5 mg D5 Logo

Tradjenta

Generic Name:
linagliptin
Imprint:
D5 Logo
Strength:
5 mg
Color:
Red
Shape:
Round
Availability:
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Boehringer Ingelheim Pharmaceuticals, Inc.
National Drug Code (NDC):
00597-0140

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide